Arcon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 31-05-2024
- Paid Up Capital ₹ 0.20 M
as on 31-05-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.06 M
as on 31-05-2024
- Revenue -45.03%
(FY 2021)
- Profit -47.94%
(FY 2021)
- Ebitda 178.32%
(FY 2021)
- Net Worth 26.06%
(FY 2021)
- Total Assets 9.15%
(FY 2021)
About Arcon Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.06 M.
Rakesh Kumar and Ritesh Kumar serve as directors at the Company.
- CIN/LLPIN
U51397BR2011PTC016815
- Company No.
016815
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2011
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arcon Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritesh Kumar  | Managing Director | 07-Apr-2011 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Kumar | Director | 07-Apr-2011 | Current |
Financial Performance of Arcon Pharmaceuticals.
Arcon Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 45.03% decrease. The company also saw a substantial fall in profitability, with a 47.94% decrease in profit. The company's net worth Soared by an impressive increase of 26.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arcon Pharmaceuticals?
Unlock access to Arcon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 26 Aug 2020 | ₹1.06 M | Open |
How Many Employees Work at Arcon Pharmaceuticals?
Unlock and access historical data on people associated with Arcon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arcon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arcon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
